Maternus-Kliniken Aktiengesellschaft (FRA:MAK)
Germany · Delayed Price · Currency is EUR 1.080
+0.010 (0.93%)
Last updated: Sep 30, 2025, 8:02 AM CET
FRA:MAK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 116.17 | 114 | 102.31 | 106.7 | 111.44 | 114.3 | Upgrade |
Other Revenue | 1.11 | - | - | - | - | - | Upgrade |
| 117.28 | 114 | 102.31 | 106.7 | 111.44 | 114.3 | Upgrade | |
Revenue Growth (YoY) | 5.43% | 11.43% | -4.12% | -4.25% | -2.50% | -8.14% | Upgrade |
Cost of Revenue | 91.97 | 91.67 | 94.39 | 90.27 | 82.66 | 86.79 | Upgrade |
Gross Profit | 25.31 | 22.33 | 7.91 | 16.43 | 28.78 | 27.51 | Upgrade |
Selling, General & Admin | - | - | - | 0.25 | 0.29 | 0.4 | Upgrade |
Other Operating Expenses | 17.1 | 13.77 | 7.43 | 15.32 | 16.27 | 15.27 | Upgrade |
Operating Expenses | 29.07 | 26.32 | 17.17 | 26.58 | 27.67 | 27.26 | Upgrade |
Operating Income | -3.76 | -3.99 | -9.26 | -10.14 | 1.11 | 0.26 | Upgrade |
Interest Expense | -8.49 | -8.43 | -7.55 | -5.78 | -6.01 | -7.24 | Upgrade |
Interest & Investment Income | 0.24 | 0.38 | 0.16 | 0.05 | 0.08 | 0.08 | Upgrade |
Other Non Operating Income (Expenses) | 1.7 | 1.71 | 3.97 | 0.79 | 2.65 | 1.29 | Upgrade |
EBT Excluding Unusual Items | -10.31 | -10.33 | -12.69 | -15.08 | -2.17 | -5.61 | Upgrade |
Pretax Income | -10.31 | -10.33 | -12.69 | -15.08 | -2.17 | -5.61 | Upgrade |
Income Tax Expense | 3.22 | 2.88 | 1.67 | 1.25 | 0.52 | 1.85 | Upgrade |
Earnings From Continuing Operations | -13.53 | -13.21 | -14.36 | -16.33 | -2.69 | -7.46 | Upgrade |
Minority Interest in Earnings | 0.11 | 0.06 | 0.11 | 2.25 | 0.13 | -2.17 | Upgrade |
Net Income | -13.42 | -13.16 | -14.26 | -14.08 | -2.56 | -9.62 | Upgrade |
Net Income to Common | -13.42 | -13.16 | -14.26 | -14.08 | -2.56 | -9.62 | Upgrade |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 | Upgrade |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 | Upgrade |
EPS (Basic) | -0.63 | -0.63 | -0.68 | -0.67 | -0.12 | -0.46 | Upgrade |
EPS (Diluted) | -0.63 | -0.63 | -0.68 | -0.67 | -0.12 | -0.46 | Upgrade |
Free Cash Flow | 9.8 | 13.86 | -1.44 | 2.33 | 15.33 | 11.46 | Upgrade |
Free Cash Flow Per Share | 0.46 | 0.66 | -0.07 | 0.11 | 0.73 | 0.55 | Upgrade |
Gross Margin | 21.58% | 19.59% | 7.74% | 15.40% | 25.83% | 24.07% | Upgrade |
Operating Margin | -3.21% | -3.50% | -9.05% | -9.51% | 1.00% | 0.23% | Upgrade |
Profit Margin | -11.44% | -11.54% | -13.94% | -13.19% | -2.30% | -8.42% | Upgrade |
Free Cash Flow Margin | 8.35% | 12.16% | -1.41% | 2.19% | 13.76% | 10.02% | Upgrade |
EBITDA | -1.13 | -0.77 | -6.06 | -6.95 | 4.25 | 3.47 | Upgrade |
EBITDA Margin | -0.96% | -0.68% | -5.92% | -6.52% | 3.81% | 3.04% | Upgrade |
D&A For EBITDA | 2.64 | 3.22 | 3.2 | 3.19 | 3.14 | 3.21 | Upgrade |
EBIT | -3.76 | -3.99 | -9.26 | -10.14 | 1.11 | 0.26 | Upgrade |
EBIT Margin | -3.21% | -3.50% | -9.05% | -9.51% | 1.00% | 0.23% | Upgrade |
Revenue as Reported | 126.73 | 123.46 | 114.94 | 114.29 | 119.65 | 118.23 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.